Moolec Science Sa Stock Today
| MLEC Stock | 3.88 0.05 1.27% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Moolec Science is trading at 3.88 as of the 19th of July 2025, a 1.27 percent down since the beginning of the trading day. The stock's open price was 3.93. Moolec Science has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of April 2025 and ending today, the 19th of July 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 3rd of January 2023 | Category Healthcare | Classification Health Care |
Moolec Science is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 4 M outstanding shares of which 7.09 K shares are now shorted by private and institutional investors with about 4.75 trading days to cover. More on Moolec Science SA
Moving against Moolec Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Moolec Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO CoFounder | Gaston MBA | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsMoolec Science can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Moolec Science's financial leverage. It provides some insight into what part of Moolec Science's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Moolec Science SA (MLEC) is traded on NASDAQ Exchange in USA. It is located in , United Kingdom and employs 8 people. Moolec Science is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 15.72 M. Moolec Science SA conducts business under Biotechnology sector and is part of Health Care industry. The entity has 4 M outstanding shares of which 7.09 K shares are now shorted by private and institutional investors with about 4.75 trading days to cover.
Moolec Science generates negative cash flow from operations
Check Moolec Science Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Moolec Science SA is USD15.72 Million. Moolec Science SA holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Moolec Ownership Details
Moolec Science Historical Income Statement
Moolec Stock Against Markets
Moolec Science Corporate Management
| Florencia Bottero | Corporate Board | Profile | |
| Agustin Falus | Global Controller | Profile | |
| Jose MBA | Chief Officer | Profile | |
| Amit Dhingra | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moolec Science SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moolec Science. If investors know Moolec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moolec Science listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.10) | Revenue Per Share | Quarterly Revenue Growth 9.483 | Return On Assets | Return On Equity |
The market value of Moolec Science SA is measured differently than its book value, which is the value of Moolec that is recorded on the company's balance sheet. Investors also form their own opinion of Moolec Science's value that differs from its market value or its book value, called intrinsic value, which is Moolec Science's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moolec Science's market value can be influenced by many factors that don't directly affect Moolec Science's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moolec Science's value and its price as these two are different measures arrived at by different means. Investors typically determine if Moolec Science is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moolec Science's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.